phenylpiperazine has been researched along with Breast Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bayrak, N; Jannuzzi, AT; Jayaprakash, V; Shilkar, D; TuYuN, AF; Yıldırım, H; Yıldız, M | 1 |
| Gao, LL; Guo, FJ; Qian, SS; Sun, J; Wang, XY; Zhang, Y; Zhu, HL | 1 |
2 other study(ies) available for phenylpiperazine and Breast Neoplasms
| Article | Year |
|---|---|
Anticancer agents based on Plastoquinone analogs with N-phenylpiperazine: Structure-activity relationship and mechanism of action in breast cancer cells.
Topics: Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Female; Humans; Piperazines; Plastoquinone; Structure-Activity Relationship | 2021 |
Discovery of phenylpiperazine derivatives as IGF-1R inhibitor with potent antiproliferative properties in vitro.
Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Proliferation; Female; Humans; MCF-7 Cells; Molecular Docking Simulation; Piperazines; Protein Kinase Inhibitors; Receptor, IGF Type 1 | 2015 |